Education
About Us
Working with TipRanks
Follow Us
Neuphoria Therapeutics (NEUP)
NASDAQ:NEUP
Neuphoria Therapeutics (NEUP) Ownership Overview
6.93% Other Institutional Investors
3.48% ETFs
89.59% Public Companies and
Individual Investors
The ownership structure of Neuphoria Therapeutics (NEUP) stock is a mix of institutional, retail, and individual investors. , and 89.59% is owned by Public Companies and Individual Investors.
Top Shareholders
Holder | # of Shares | Type | % Holding | Value |
|---|---|---|---|---|
| 133,550 | Insider | 8.20% | 431,367 | |
| 71,043 | Institution | 3.01% | 1,102,587 | |
| 11,072 | Institution | 0.47% | 171,837 |
Top Mutual Fund Holders
Holder | # of Shares | Type | % Holding | Value |
|---|
Top ETF Holders
Holder | # of Shares | Type | % Holding | Value |
|---|---|---|---|---|
| 71,043 | Institution | 3.01% | 1,077,722 | |
| 11,072 | Institution | 0.47% | 130,539 |
FAQ
Who Owns Neuphoria Therapeutics (NEUP)?
Currently, no data Available
What percentage of Neuphoria Therapeutics (NEUP) stock is held by institutional investors?
According to the latest TipRanks data, approximately 6.93% of Neuphoria Therapeutics (NEUP) stock is held by institutional investors.
What percentage of Neuphoria Therapeutics (NEUP) stock is held by retail investors?
According to the latest TipRanks data, approximately 89.59% of Neuphoria Therapeutics (NEUP) stock is held by retail investors.
Who owns the most shares of Neuphoria Therapeutics (NEUP)?
Weston Nichols owns the most shares of Neuphoria Therapeutics (NEUP).
What is the significance of the ownership structure for a publicly traded company?
The ownership structure can impact the company's decision making, as large institutional investors may exert influence on the company's management and can also affect the company's stock price with their buying and selling patterns.